Updated data from DESTINY-Breast01 trial continues to demonstrate efficacy
News
MHRA issues allergy warning for Pfizer/BioNTech COVID-19 jab
Updated guidance warns people with a history of allergic reactions not to receive the shot
Kite’s CAR T therapy Yescarta shows potential in new indication
ZUMA-12 phase II study is evaluating therapy as a first-line treatment for high-risk large B-cell lymphoma
Pfizer’s pneumococcal disease vaccine scores FDA priority review
Vaccine candidate previously scored fast-track and breakthrough therapy designations
Novartis signs AI ophthalmology pact with RetinAI
Agreement will utilise RetinAI’s IT solutions and artificial intelligence tools to support projects in ophthalmology
Winners shine bright at PharmaTimes Awards
Meet the winners of the 2020 PharmaTimes Marketer of the Year, Communications Awards and Sales Awards
Roche reveals new bispecific antibody data in blood cancers
‘Encouraging’ data for investigational candidates across a range of blood cancers
NICE backs AZ’ Calquence for chronic lymphocytic leukaemia
The recommendations are positive for a select population of patients with CLL
Two medicines accepted for use by NHS Scotland
Medicines for blood cancer and a rare muscle disorder will be made available for NHS patients
CR UK makes further cuts in COVID’s wake
The charity is slashing £45 million from its research budget
World first as UK launches COVID-19 vaccination programme
A 90 year-old woman in Coventry has become the first person in the UK to be given the vaccine
Calquence shows long-term efficacy and tolerability in MCL
Patients with relapsed or refractory mantle cell lymphoma (MCL) treated with AstraZeneca’s Calquence remained progression free for a median of 22 months
Research highlights benefit of telemedicine for stroke treatment
Around one in five stroke patients could go undiagnosed with the tests currently used by paramedics
Valneva fast-tracks paediatric development of Lyme disease vaccine
Company plans phase II study launch in first quarter of 2021
UK launch for Vagirux
The drug is administered intravaginally as a local oestrogen therapy for treatment of vaginal atrophy due to oestrogen deficiency.
